Zions Bancorporation National Association UT Buys New Holdings in CME Group Inc. (NASDAQ:CME)

Key Points

• Zions Bancorporation National Association UT has acquired a new stake in CME Group Inc., purchasing 2,396 shares valued at approximately $636,000.
• CME Group announced a quarterly dividend of $1.25, which represents an annualized dividend yield of 1.8%.
• During the last quarter, CME Group reported an EPS of $2.96, exceeding analysts' expectations and showing a 10.4% year-over-year rise in revenue.

Zions Bancorporation National Association UT bought a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,396 shares of the financial services provider's stock, valued at approximately $636,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wayfinding Financial LLC purchased a new position in CME Group in the first quarter valued at approximately $25,000. Cornerstone Planning Group LLC raised its holdings in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares during the period. Golden State Wealth Management LLC increased its holdings in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the period. Alpine Bank Wealth Management bought a new position in shares of CME Group in the first quarter worth $32,000. Finally, Financial Gravity Asset Management Inc. bought a new position in shares of CME Group in the first quarter worth $32,000. 87.75% of the stock is owned by institutional investors.

CME Group Trading Up 0.4%

NASDAQ CME opened at $282.21 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market cap of $101.70 billion, a PE ratio of 27.32, a price-to-earnings-growth ratio of 5.01 and a beta of 0.44. The company has a 50 day moving average price of $275.84 and a 200 day moving average price of $265.90. CME Group Inc. has a 52 week low of $203.77 and a 52 week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the business posted $2.56 EPS. CME Group's revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's payout ratio is currently 48.40%.

Insider Transactions at CME Group

In other news, Director William R. Shepard purchased 256 shares of the stock in a transaction that occurred on Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This represents a 0.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Daniel G. Kaye sold 500 shares of the stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director directly owned 3,668 shares in the company, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,750 shares of company stock valued at $1,576,294. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CME. UBS Group reissued a "neutral" rating and issued a $305.00 target price on shares of CME Group in a research note on Thursday, July 24th. Keefe, Bruyette & Woods boosted their price target on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Barclays set a $298.00 price objective on shares of CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Piper Sandler raised their target price on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Finally, Oppenheimer raised their price target on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research report on Thursday, July 24th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.